Jennifer J. Fowler

Jennifer J. Fowler

Auto-generated profile, based on publicly available information

Jennifer J. Fowler

Division of Global Migration Health, National Center for Emerging Zoonotic and Infectious Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2025 in Zoonoses and Public Health
Verified
Journal Article
Closed access
SSSamantha Swisher
Samantha Swisher
STSheena Tarrant
Sheena Tarrant
KKKaitlyn Krus
Kaitlyn Krus
FCFrancis Chu
Francis Chu
ACAnne Carroll
Anne Carroll
EPEmily Pieracci
Emily Pieracci

21 October 2025 in Journal of Public Health Management & Practice
Verified
Journal Article
Closed access
KPKristen Pringle
Kristen Pringle
RCRobert Mason Clark
Robert Mason Clark
JFJennifer J Fowler
Jennifer J Fowler
SGShannon L Gearhart
Shannon L Gearhart
LHLeslie Hausman
Leslie Hausman
AGAlida M Gertz
Alida M Gertz
Context: Pertussis is endemic worldwide, and exposure can occur anywhere, including commercial aircraft. Travelers exposed to an infectious person with pertussis may receive post-exposure prophylaxis (PEP) for up to 21 days after exposure to decrease risk of infection. This is accomplished through the identification of infectious travelers and their aircraft contacts (a process called aircraft contact investigation [Air CIs]). Objective: Describe travelers reported to the US Centers for Disease Control and Prevention (CDC) who flew while infectious with pertussis and outcomes of associated Air CIs. Design: CDC’s Port Health Activity Reporting System (PHARS) was queried to identify reports of travelers who flew with pertussis from April 12, 2013, to February 28, 2024. Participants: Index cases (passengers or crew members) with pertussis who traveled on commercial aircraft and their exposed passenger contacts. Main Outcome Measure(s): Traveler demographics, flight characteristics, outcome data from Air CIs. Results: Three hundred and eight individuals who recently traveled on commercial aircraft with pertussis were identified. Of the passengers determined to be infectious on the flights, Air CIs were initiated for 102/270 (38%) travelers who flew on 163/500 (33%) flights. Among the 337/500 (67%) flights for which Air CI was not initiated, the most common reason was that the index case was seated adjacent to only household members (142/337, 42%). For flights in which Air CIs were initiated, 234 contacts were identified, and one secondary case in a non-household passenger contact was reported. The average time from when contacts were exposed during the flight to when a health department reported the index case to CDC was 11.6 days (median 10.3 days, range: 0-39 days). Conclusions: Timely reporting of pertussis cases after air travel may decrease transmission risk to passenger contacts and prevent severe illness.

21 October 2025 in Journal of Public Health Management & Practice
Verified
Journal Article
Closed access
LRLily Rubin
Lily Rubin
JFJennifer Fowler
Jennifer Fowler
SRSrikar Ranga
Srikar Ranga
MKMáire Kirley
Máire Kirley
JTJoshua Tchan
Joshua Tchan
AGAlida M. Gertz
Alida M. Gertz
Objectives: The Centers for Disease Control and Prevention (CDC) maintains a formulary of biologic agents and drugs not available commercially in the United States. For a subset of these (botulism and diphtheria antitoxins and, until 2022, intravenous artesunate for severe malaria), distribution is coordinated through CDC port health stations (PHS), located mainly at major US international airports. CDC aims for these drugs to reach their destinations within 8 hours of release authorization. We analyzed CDC records to identify areas for efficiency improvement. Design: We queried records detailing drug distributions from PHS that occurred May 2006 to February 2024, including timing of release authorization and delivery, geographic origins and destinations, mode of transportation, and patient characteristics and outcomes. We conducted descriptive and multivariate analyses to identify variables that may have delayed delivery. Setting: CDC port health stations. Main Outcome Measures: Time from release authorization to drug delivery. Results: CDC PHS distributed 2912 drug shipments between May 2006 and February 2024 via 17 distribution sites to 54 jurisdictions across the US and 3 countries. Of 850 shipments for which data were available (those occurring December 2019 or later), 83% (n = 702/850) occurred within 8 hours of authorization. Commercial air transport (compared to other types of transport) (aOR: 11.43, 95% confidence interval [CI]: 6.94-18.81, P < .001) and release authorization time (outside of vs within routine work hours) (aOR: 5.10, 95% CI: 3.31-7.86, P < .001) were significantly associated with delays. Conclusions: CDC PHS facilitated emergency distributions of life-saving drugs for botulism, diphtheria, and severe malaria to locations throughout the US mostly within 8 hours of authorization. Staffing, distribution locations, and expanded options for ground transportation are important considerations that may minimize delays.

27 February 2026 in The Journal of Infectious Diseases
Verified
Journal Article
Closed access
JFJennifer J Fowler
Jennifer J Fowler
AMAmanda Metz
Amanda Metz
MBMeghan Barnes
Meghan Barnes
SGShannon L Gearhart
Shannon L Gearhart
TFThomas Daniel Filardo
Thomas Daniel Filardo
AGAlida M Gertz
Alida M Gertz
Background: Travelers who fly on commercial aircraft while infectious with measles are reported to the US Centers for Disease Control and Prevention (CDC) by health departments. CDC contacts airlines to collect information on potentially exposed travelers. Traveler locating information is shared with health departments to facilitate aircraft contact investigations. In May 2025, CDC was notified of a traveler who flew from Europe to Colorado while infectious with measles, transited through Denver International Airport, then flew from Colorado to North Dakota. This report describes details of the subsequent contact investigations, environmental assessment, and laboratory testing results. Methods: CDC laboratories conducted testing on a majority of case samples. Data from the CDC laboratory, CDC's Port Health Activity Reporting System, and health department investigations were analyzed to describe the index case, contacts, test results, and travel details. Flight records and visual inspection were used to describe relative locations of index and secondary case-patients at Denver International Airport. Results: The index case was in an unvaccinated adult. Aircraft contact investigations identified 135 exposed domestic travelers. Fifteen secondary cases were identified among people exposed during the international (5) and domestic (3) flights and at the airport (7). Two tertiary case-patients were also identified. Five of the secondary case-patients had at least 1 documented prior measles vaccination. Conclusions: Measles transmission may occur during travel. Measles vaccination is recommended prior to international travel for all travelers aged 6 months or older. Travelers with fever and other overt signs of transmissible illness, such as coughing or malaise, should be strongly encouraged to delay travel while symptomatic.